Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Meares

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Clinical Lymphoma|November 15, 2001
Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphomaG L DeNardo, S J DeNardo, R T O'Donnell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1987
Comparative serum stability of radiochelates for antibody radiopharmaceuticalsW C Cole, S J DeNardo, C F Meares, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Serum stability of 67Cu chelates: comparison with 111In and 57CoW C Cole, S J DeNardo, C F Meares, et al.
Molecular Immunology|December 11, 1999
Critical Lym-1 binding residues on polymorphic HLA-DR moleculesL M Rose, C T Deng, S L Scott, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Macrocyclic chelates of radiometals for diagnosis and therapyC F Meares, M K Moi, H Diril, et al.
Cancer|February 1, 1994
Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3)G L DeNardo, L A Kroger, S J DeNardo, et al.
Nature|July 18, 1985
Antibodies against metal chelatesD T Reardan, C F Meares, D A Goodwin, et al.
Cancer Research|November 15, 1994
Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapyD A Goodwin, C F Meares, N Watanabe, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticalsD A Goodwin, C F Meares, G F David, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1992
Copper-64-labeled antibodies for PET imagingC J Anderson, J M Connett, S W Schwarz, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Clinical Lymphoma|November 15, 2001
Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphomaG L DeNardo, S J DeNardo, R T O'Donnell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1987
Comparative serum stability of radiochelates for antibody radiopharmaceuticalsW C Cole, S J DeNardo, C F Meares, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Serum stability of 67Cu chelates: comparison with 111In and 57CoW C Cole, S J DeNardo, C F Meares, et al.
Molecular Immunology|December 11, 1999
Critical Lym-1 binding residues on polymorphic HLA-DR moleculesL M Rose, C T Deng, S L Scott, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Macrocyclic chelates of radiometals for diagnosis and therapyC F Meares, M K Moi, H Diril, et al.
Cancer|February 1, 1994
Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3)G L DeNardo, L A Kroger, S J DeNardo, et al.
Nature|July 18, 1985
Antibodies against metal chelatesD T Reardan, C F Meares, D A Goodwin, et al.
Cancer Research|November 15, 1994
Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapyD A Goodwin, C F Meares, N Watanabe, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticalsD A Goodwin, C F Meares, G F David, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1992
Copper-64-labeled antibodies for PET imagingC J Anderson, J M Connett, S W Schwarz, et al.
Pageof 15